Недвигательные нарушения при цервикальной дистонии
https://doi.org/10.14412/2074-2711-2018-3-135-140
Аннотация
Инъекционная терапия препаратами ботулотоксина составляет основу ведения пациентов с двигательными проявлениями дистонии. У таких пациентов важно выявить возможные когнитивные и психические нарушения, расстройства сна и восприятия (недвигательные нарушения). Коррекция этих расстройств позволит оптимизировать лечение, улучшить качество жизни пациентов.
Об авторах
В. А. Толмачева
ФГАОУ ВО «Первый Московский государственный медицинский
университет им. И.М. Сеченова (Сеченовский университет)» Минздрава России, Москва
Россия
Кафедра нервных болезней и нейрохирургии лечебного факультета
Россия
Кафедра нервных болезней и нейрохирургии лечебного факультета
М. Р. Нодель
ФГАОУ ВО «Первый Московский государственный медицинский
университет им. И.М. Сеченова (Сеченовский университет)» Минздрава России, Москва;
Российский научно-клинический геронтологический центр ФГБОУ ВО «Российский национальный исследовательский медицинский
университет им. Н.И. Пирогова» Минздрава России, Москва
Россия
Россия
Кафедра нервных болезней и нейрохирургии лечебного факультета;
Научно-исследовательский отдел неврологии научно-технологического парка биомедицины
Н. И. Салоухина
БУЗ Орловской области «Орловская областная клиническая больница», Орел
Россия
Россия
Список литературы
1. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013 Jun 15; 28(7):863-73. doi: 10.1002/mds.25475. Epub 2013 May 6.
2. Simpson DM, Blitzer A, Brashear A. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidencebased review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 May 6;70(19):1699-706. doi: 10.1212/01.wnl.0000311389.26145.95.
3. Findley L, Eichhorn T, Janca A, et al. Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Mov Disord. 2002 Jan;17(1):60-7. doi: 10.1002/mds.10010.
4. Lö hle M, Storch A, Reichmann H. Beyond tremor and rigidity: Non-motor features of Parkinson's disease. J Neural Transm (Vienna). 2009 Nov;116(11):1483-92. doi: 10.1007/ s00702-009-0274-1. Epub 2009 Aug 14.
5. Wolters EC. Non-motor extranigral signs and symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S6-12.
6. doi: 10.1016/S1353-8020(09)70770-9.
7. Eichenseer SR, Stebbins GT, Comella CL. Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia. Parkinsonism Relat Disord. 2014 Apr;20(4): 405-8. doi: 10.1016/j.parkreldis.2014.01.004. Epub 2014 Jan 15.
8. Ben-Shlomo Y, Camfield L, Warner T. What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry. 2002 May;72(5):608-14.
9. Page D, Butler A, Jahanshahi M. Quality of life in focal, segmental, and generalized dystonia. Mov Disord. 2007 Feb 15;22(3):341-7.
10. Pekmezovic T, Svetel M, Ivanovic N, et al. Quality of life in patients with focal dystonia. Clin Neurol Neurosurg. 2009 Feb;111(2):161-4. doi: 10.1016/j.clineuro.2008.09.023. Epub 2008 Nov 7.
11. Klingelhoefer L, Martino D, Martinez-Martin P, et al. Nonmotor symptoms and focal cervical dystonia: observations from 102 patients. Basal Ganglia. 2014 Dec;4(3-4): 117-20. Doi: 10.1016/j.baga.2014.10.002
12. Paus S, Gross J, Moll-Mü ller M, et al. Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: A controlled study. J Neurol. 2011 Oct;258(10):1835-40. doi: 10.1007/s00415-011-6029-6. Epub 2011 Apr 16.
13. Avanzino L, Martino D, Marchese R, et al. Quality of sleep in primary focal dystonia: A casecontrol study. Eur J Neurol. 2010 Apr;17(4):576-81. doi: 10.1111/j.1468-1331.2009.02884.x. Epub 2009 Dec 18.
14. Defazio G, Jankovic J, Giel JL, Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y). 2013 Nov 4;3. pii: tre-03-193-4374-2. doi: 10.7916/D80C4TGJ. eCollection 2013.
15. Lehericy S, Tijssen MAJ, Vidailhet M, et al. The anatomical basis of dystonia: Current view using neuroimaging. Mov Disord. 2013 Jun 15;28(7):944-57. doi: 10.1002/mds.25527.
16. Steeves TD, Day L, Dykeman J, et al. The prevalence of primary dystonia: a systematic review and meta- analysis. Mov Disord. 2012 Dec;27(14):1789-96. doi: 10.1002/mds.25244. Epub 2012 Oct 31.
17. Papathanasiou I, MacDonald L, Whurr R, Jahanshahi M. Perceived stigma in spasmodic torticollis. Mov Disord. 2001 Mar;16(2):280-5.
18. Trotti LM, Esper CD, Feustel PJ, et al. Excessive daytime sleepiness in cervical dystonia. Parkinsonism Relat Disord. 2009 Dec;15(10): 784-6. doi: 10.1016/j.parkreldis.2009.04.007. Epub 2009 May 15.
19. Lobbezoo F, Thu Thon M, Remillard G, et al. Relationship between sleep, neck muscle activity, and pain in cervical dystonia. Can J Neurol Sci. 1996 Nov;23(4):285-90.
20. Sforza E, Montagna P, Defazio G, Lugaresi E. Sleep and cranial dystonia. Electroencephalogr Clin Neurophysiol. 1991 Sep;79(3):166-9.
21. Duane DD. Spasmodic torticollis. Adv Neurol. 1988;49:135-50.
22. Kutvonen O, Dastidar P, Nurmikko T. Pain in spasmodic torticollis. Pain. 1997 Feb;69(3): 279-86.
23. Lowenstein DH, Aminoff MJ. The clinical course of spasmodic torticollis. Neurology. 1988 Apr;38(4):530-2.
24. Defazio G, Berardelli A, Abbruzzese G,
25. et al. Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1): 25-32.
26. Tinazzi M, Rosso T, Fiaschi A. Role of the somatosensory system in primary dystonia. Mov Disord. 2003 Jun;18(6):605-22.
27. Conte A, Berardelli I, Ferrazzano G, et al. Non-motor symptoms in patients with adultonset focal dystonia: Sensory and psychiatric disturbances. Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S111-4. doi: 10.1016/j.parkreldis.2015.09.001. Epub 2015 Sep 3.
28. Bradley D, Whelan R, Walsh R, et al. Temporal discrimination threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia. Brain. 2009 Sep;132 (Pt 9):2327-35. doi: 10.1093/brain/awp156. Epub 2009 Jun 12.
29. Firma N, Nasir J, Grü newald RA. Abnormal vibration-induced illusion of movement in idiopathic focal dystonia: An endophenotypic marker? Mov Disord. 2008 Feb 15;23(3): 373-7.
30. Molloy FM, Carr TD, Zeuner KE, et al. Abnor-malities of spatial discrimination in focal and generalized dystonia. Brain. 2003 Oct; 126(Pt 10):2175-82. Epub 2003 Jun 23.
31. Putzki N, Stude P, Konczak J, et al. Kinesthesia is impaired in focal dystonia. Mov Disord. 2006 Jun;21(6):754-60.
32. Bradley D, Whelan R, Kimmich O, et al. Temporal discrimination thresholds in adultonset primary torsion dystonia: An analysis by task type and by dystonia phenotype. J Neurol. 2012 Jan;259(1):77-82. doi: 10.1007/s00415-011-6125-7. Epub 2011 Jun 8.
33. Conte A, Rocchi L, Ferrazzano G, et al. Primary somatosensory cortical plasticity and tactile temporal discrimination in focal hand dystonia. Clin Neurophysiol. 2014 Mar;125(3): 537-43. doi: 10.1016/j.clinph.2013.08.006. Epub 2013 Sep 6.
34. Tamura Y, Matsuhashi M, Lin P, et al. Impaired intracortical inhibition in the primary somatosensory cortex in focal hand dystonia. Mov Disord. 2008 Mar 15;23(4):558-65.
35. Walsh RA, Whelan R, O'Dwyer J, et al. Striatal morphology correlates with sensory abnormalities in unaffected relatives of cervical dystonia patients. J Neurol. 2009 Aug;256(8): 1307-13. doi: 10.1007/s00415-009-5119-1. Epub 2009 Apr 8.
36. Belvisi D, Suppa A, Marsili L, et al. Abnormal experimentally- and behaviorallyinduced LTP-like plasticity in focal hand dystonia. Exp Neurol. 2013 Feb;240:64-74. doi: 10.1016/j.expneurol.2012.11.003. Epub 2012 Nov 8.
37. Gü ndel H, Wolf A, Xidara V, et al. High psychiatric comorbidity in spasmodic torticollis: A controlled study. J Nerv Ment Dis. 2003 Jul; 191(7):465-73.
38. Rome S, Grü newald R. Abnormal perception of vibration-induced illusion of movement in dystonia. Neurology. 1999 Nov 10;53(8): 1794-800.
39. Heiman GA, Ottman R, Saunders-Pullman RJ, et al. Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology. 2004 Aug 24;63(4): 631-7.
40. Jankovic J, Leder S, Warner D, Schwartz K. Cervical dystonia: Clinical find-ings and associated movement disorders. Neurology. 1991 Jul; 41(7):1088-91.
41. Kuyper DJ, Parra V, Aerts S, et al. The nonmotor manifestations of dystonia: A systematic review. Mov Disord. 2011 Jun;26(7):1206-17. doi: 10.1002/mds.23709. Epub 2011 Apr 11.
42. Орлова ОР. Фокальные дистонии: клиника, патогенез, лечение с использованием токсина ботулизма. Дис. докт. мед. наук. Москва; 2000. С. 13. [Orlova OR. Focal dystonia: clinical features, pathogenesis, treatment using botulinum toxin. Diss. doct. med. sci. Moscow; 2000. P. 13.]
43. Fabbrini G, Berardelli I, Moretti G, et al. Psychiatric disorders in adult-onset focal dystonia: A case-control study. Mov Disord. 2010 Mar 15;25(4):459-65. doi: 10.1002/mds.22983.
44. Lauterbach EC, Freeman A, Vogel RL. Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's disease. The J Neuropsychiatry Clin Neurosci. 2004 Winter;16(1):29-36.
45. Lencer R, Steinlechner S, Stahlberg J, et al. Primary focal dystonia: Evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1176-9. doi: 10.1136/jnnp.2008.170191. Epub 2009 May 21.
46. Gü ndel H, Wolf A, Xidara V, et al. Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):499-504.
47. Miller KM, Okun MS, Fernandez HF, et al. Depression symptoms in movement disorders: Comparing Parkinson's disease, dystonia, and essential tremor. Mov Disord. 2007 Apr 15;22(5): 666-72.
48. Wenzel T, Schnider P, Wimmer A, et al. Psychiatric comorbidity in patients with spasmodic torticollis. J Psychosom Res. 1998 Jun; 44(6):687-90.
49. Stamelou M, Edwards MJ, Hallett M, Bhatia KP. The non-motor syndrome of primary dystonia: Clinical and pathophysiological implications. Brain. 2012 Jun;135(Pt 6): 1668-81. doi: 10.1093/brain/awr224. Epub 2011 Sep 20.
50. Vuilleumier P, Chicherio C, Assal F, et al. Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain. 2001 Jun; 124(Pt 6):1077-90.
51. Gong Q, He Y. Depression, neuroimaging and connectomics: a selective overview. Biol Psychiatry. 2015 Feb 1;77(3):223-235.
52. doi: 10.1016/j.biopsych.2014.08.009. Epub 2014 Aug 23.
53. Sexton CE, Mackay CE, Ebmeier KP. A systematic review and meta-analysis of magnetic resonance imaging studies in late- life depression. Am J Geriatr Psychiatry. 2013 Feb; 21(2):184-95. doi: 10.1016/j.jagp.2012.10.019. Epub 2013 Jan 22.
54. Lewis L, Butler A, Jahanshahi M. Depression in focal, segmental and generalized dystonia. J Neurol. 2008 Nov;255(11):1750-5. doi: 10.1007/s00415-008-0020-x. Epub 2008 Nov 13.
55. Muller J, Kemmler G, Wissel J, et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol. 2002 Jul;249(7):842-6.
56. Jankovic J, Leder S, Warner D, Schwartz K. Cervical dystonia: Clinical findings and associated movement disorders. Neurology. 1991 Jul; 41(7):1088-91.
57. Jahanshahi M, Marsden CD. A longitudinal follow-up study of depression, disability, and body concept in torticollis. Behav Neurol. 1990;3(4):233-46. doi: 10.3233/BEN-1990-3403.
58. Moraru E, Schnider P, Wimmer A, et al. Relation between depression and anxiety in dystonic patients: Implications for clinical management. Depress Anxiety. 2002;16(3): 100-3.
59. Tiple D, Strano S, Colosimo C, et al. Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type a. J Neurol. 2008 Jun;255(6):843-7. doi: 10.1007/s00415-008-0753-6. Epub 2008 May 7.
60. Romano R, Bertolino A, Gigante A, et al. Impaired cognitive functions in adult- onset primary cranial cervical dystonia. Parkinsonism Relat Disord. 2014 Feb;20(2):162-5. doi: 10.1016/j.parkreldis.2013.10.008. Epub 2013 Oct 17.
61. Loetscher T, McDonnell M, Bradnam L. Impaired cognitive functioning in cervical dystonia. Front. Hum. Neurosci. Conference Abstract: XII International Conference on Cognitive Neuroscience (ICON-XII). 2015; 271. doi: 10.3389/conf.fnhum.2015.217.00271.
62. Jahanshahi M. Psychosocial factors and depression in torticollis. J Psychosom Res. 1991;35(4-5):493-507.
63. Slawek J, Friedman A, Potulska A, et al. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections. Funct Neurol. 2007 Apr-Jun;22(2):95-100.
64. Soeder A, Kluger BM, Okun MS, et al. Mood and energy determinants of quality of life in dystonia. J Neurol. 2009 Jun;256(6):996-1001. doi: 10.1007/s00415-009-5060-3. Epub 2009 Mar 10.
65. Jahanshahi M, Marsden CD. Body concept, disability, and depression in patients with spasmodic torticollis. Behav Neurol. 1990;3(4): 233-46. doi: 10.3233/BEN-1990-3403.
66. Smit M, Kuiper A, Han V, et al. Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study. Parkinsonism Relat Disord. 2016 Sep; 30:7-12. doi: 10.1016/j.parkreldis.2016.06.004. Epub 2016 Jun 8.
67. Cano SJ, Warner TT, Linacre JM, et al. Capturing the true burden of dystonia on patients: The cervical dystonia impact profile (CDIP-58). Neurology. 2004 Nov 9;63(9): 1629-33.
68. Whurr R, Nye C, Lorch M. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: A review of 22 studiesInt. J Lang Commun Disord. 1998;33 Suppl:327-9.
Рецензия
Для цитирования:
Толмачева ВА, Нодель МР, Салоухина НИ. Недвигательные нарушения при цервикальной дистонии. Неврология, нейропсихиатрия, психосоматика. 2018;10(3):135-140. https://doi.org/10.14412/2074-2711-2018-3-135-140
For citation:
Tolmacheva VA, Nodel MR, Saloukhna NI. Non-motor disorders in cervical dystonia. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):135-140. (In Russ.) https://doi.org/10.14412/2074-2711-2018-3-135-140
Просмотров:
623
Послать статью по эл. почте 